A phase II study of treatment of painful multifocal skeletal metastases with single and repeated dose samarium-153 ethylenediaminetetramethylene phosphonate
- 30 September 1991
- journal article
- clinical trial
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 27 (9) , 1084-1086
- https://doi.org/10.1016/0277-5379(91)90297-q
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Re-186(Sn) HEDP for treatment of painful osseous metastases: initial clinical experience in 20 patients with hormone-resistant prostate cancer.Radiology, 1990
- A phase I study of samarium-153 ethylenediaminetetramethylene phosphonate therapy for disseminated skeletal metastases.Journal of Clinical Oncology, 1989
- Samarium ? 153 EDTMP therapy of disseminated skeletal metastasisEuropean Journal of Nuclear Medicine and Molecular Imaging, 1989